Clinical trial
Trial of Rifaximin in Probable Alzheimer's Disease
NCT03856359
Study timeline
Study start (actual)2019-04-09Date precision: day
Registry last updated2021-12-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
Sponsors & collaborators
Duke Universitylead sponsor
Bausch Health Americas, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03856359 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.